Covered recipient · General Payments record
CHANDRASEKAR DHEENAN
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$3,574.67
- Reported across 204 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $460.41 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $286.64 | 18 |
| Sumitomo Pharma America, Inc. | $49.48 | 3 |
| Medtronic, Inc. | $35.50 | 2 |
| Astellas Pharma US Inc | $33.96 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.75 | 1 |
| Endo USA, Inc. | $17.09 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.11 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635594 | CMS |
| ABBVIE INC. | $16.64 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635596 | CMS |
| ABBVIE INC. | $16.50 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635598 | CMS |
| ABBVIE INC. | $6.14 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635600 | CMS |
| ABBVIE INC. | $5.23 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635602 | CMS |
| ABBVIE INC. | $18.08 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635604 | CMS |
| ABBVIE INC. | $16.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635606 | CMS |
| ABBVIE INC. | $16.12 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635608 | CMS |
| ABBVIE INC. | $19.21 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635610 | CMS |
| ABBVIE INC. | $6.74 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635612 | CMS |
| ABBVIE INC. | $16.47 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635614 | CMS |
| ABBVIE INC. | $12.86 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635616 | CMS |
| ABBVIE INC. | $8.09 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635618 | CMS |
| ABBVIE INC. | $25.56 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635620 | CMS |
| ABBVIE INC. | $29.34 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635622 | CMS |
| ABBVIE INC. | $5.41 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635624 | CMS |
| ABBVIE INC. | $34.15 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635626 | CMS |
| ABBVIE INC. | $21.42 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103635628 | CMS |
| Astellas Pharma US Inc | $16.98 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139286124 | CMS |
| Astellas Pharma US Inc | $16.98 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299378 | CMS |
| Boston Scientific Corporation | $16.99 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092505569 | CMS |
| Endo USA, Inc. | $17.09 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138579665 | CMS |
| Medtronic, Inc. | $18.73 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119494492 | CMS |
| Medtronic, Inc. | $16.77 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119494494 | CMS |
| Novartis Pharmaceuticals Corporation | $20.75 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086955885 | CMS |
| Sumitomo Pharma America, Inc. | $15.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148845135 | CMS |
| Sumitomo Pharma America, Inc. | $19.97 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148845137 | CMS |
| Sumitomo Pharma America, Inc. | $14.01 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148845139 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.